Molnupiravir by Merck

Molnupiravir

Merck Sharp and Dohme (MSD) developed molnupiravir in collaboration with Ridgeback Biotherapeutics. "Molnupiravir is the oral prodrug of beta-D-N4-hydroxycytidine (NHC), a ribonucleoside that has shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials. NHC uptake by viral RNA-dependent…
Digital surveillance

Digital ID – surveillance

Digital surveillance will help usher in a China-style "social credit system" for the entire world. The technologies are available now that will start being used on your phone, and migrate to under your skin, maybe even within your body (nanotechnology)…